EPX and cancer: It is firmly established that replicative DNA polymerases become error-prone through loss of exonuclease domains (residing in amino acids 268–471 of Pol ε and 304–533 of POLD1) which compromise proof-reading activity and predispose to mutagenic activity and cancer [21].